SCHEDULE: Artisan Partners Reports 8.1% Stake in Veracyte

Artisan Partners reports beneficial ownership of 8.1% of Veracyte's common stock as of June 30, 2025.

Summary

• Artisan Partners Asset Management Inc., along with Artisan Partners Holdings LP, Artisan Investments GP LLC, and Artisan Partners Limited Partnership, filed a Schedule 13G amendment for Veracyte, Inc.
• As of June 30, 2025, Artisan Partners beneficially owns 6,321,775 shares of Veracyte's common stock.
• This represents 8.1% of the outstanding shares, based on 78,314,611 shares outstanding as of May 2, 2025.
• Artisan Partners has shared voting power over 5,220,102 shares and shared dispositive power over 6,321,775 shares.
• The shares are held on behalf of discretionary clients of Artisan Partners Limited Partnership.

Sentiment

Score: 6

Explanation: The sentiment is neutral. The filing simply reports a change in ownership stake, without expressing positive or negative views on the company.

Positives

• Artisan Partners' significant stake indicates confidence in Veracyte's prospects.
• The filing confirms Artisan Partners' position as a major shareholder.

Future Outlook

NA

Industry Context

This filing reflects institutional investment activity in the diagnostics and genomics sector, where Veracyte operates.

Stakeholder Impact

• Shareholders: The filing informs shareholders about a significant institutional ownership position.
• Company: Veracyte is informed of a change in its shareholder base.

Key Dates

Recommendation

The filing indicates a significant ownership stake by Artisan Partners, suggesting confidence in the company. However, without additional information on company performance or future plans, a hold recommendation is appropriate.

Keywords

Veracyte, Artisan Partners, Shareholding, Schedule 13G, Beneficial Ownership, Investment